Factors associated with first- and second-line attrition among metastatic breast cancer patients

被引：0

|

作者：

Blondeaux, Eva

Boni, Luca

Chila, Giovanna

Dri, Arianna

Caputo, Roberta

Poggio, Francesca

Fabi, Alessandra

Arpino, Grazia

Pravisano, Federico

Geuna, Elena

Ruelle, Tommaso

Giannubilo, Irene

de Laurentiis, Michelino

Puglisi, Fabio

Bighin, Claudia

Lambertini, Matteo

Montemurro, Filippo

Del Mastro, Lucia

机构：

来源：

CANCER RESEARCH | 2024年 / 84卷 / 09期

关键词：

D O I：

10.1158/1538-7445.SABCS23-PO3-06-01

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO3-06-01

引用

收藏

页数：3

相关论文

共 50 条

[41] Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment - Prognostic factors
Brun, B
Benchalal, M
Lebas, C
Piedbois, P
Lin, M
Lebourgeois, JP
CANCER, 1997, 79 (11) : 2137 - 2146
[42] Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: A prospective randomized trial
Joensuu, H
Holli, K
Heikkinen, M
Suonio, E
Aro, AR
Hietanen, P
Huovinen, R
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3720 - 3730
[43] Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: A prospective randomized trial
Tanner, J
Dunst, J
STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (09) : 471 - 471
[44] ANAKINRA FIRST- OR SECOND-LINE IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
Klein, A.
Hospach, A.
Foeldvari, I.
Horneff, G.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 482 - 482
[45] Cost utility in second-line metastatic breast cancer - Reply
Launois, R
ReboulMarty, J
Henry, B
Bonneterre, J
PHARMACOECONOMICS, 1997, 11 (05) : 495 - 497
[46] Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer
Christoph C. Zielinski
Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 33 - 36
[47] The in vitro activity of Cabozantinib as first- and second-line agent in metastatic renal cell carcinoma
Zaccagnino, Angela
Vynnytska-Myronovska, Bozhena
Stoeckle, Michael
Junker, Kerstin
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 102 - 102
[48] Taxotere as second-line chemotherapy for metastatic breast cancer.
Culine, S
REVUE DE MEDECINE INTERNE, 1999, 20 (03): : 277 - 280
[49] Treatment choices for second-line chemotherapy of metastatic breast cancer
Zielinski, CC
BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 : S33 - S36
[50] Ca 19.9 as an early predictor of response to first- and second-line treatment in patients with pancreatic cancer
Squadroni, M.
Berardi, R.
Tummarello, D.
Scartozzi, M.
Carbonari, G.
Pierantoni, C.
Maccarone, E.
Cascinu, S.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →